| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |